EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Surgery Partners's enterprise value is €5,735 Mil.
Surgery Partners's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was €440 Mil. Therefore, Surgery Partners's EV-to-EBITDA for today is 13.05.
The historical rank and industry rank for Surgery Partners's EV-to-EBITDA or its related term are showing as below:
FRA:1SP'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.27 Med: 21.01 Max: 45.89
Current: 13.05
During the past 12 years, the highest EV-to-EBITDA of Surgery Partners was 45.89. The lowest was 11.27. And the median was 21.01.
FRA:1SP's EV-to-EBITDA is ranked worse than 50.22% of 464
companies
in the Healthcare Providers & Services industry
Industry Median: 12.94
vs FRA:1SP: 13.05
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Surgery Partners EV-to-EBITDA Historical Data
The historical data trend for Surgery Partners's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Surgery Partners's EV-to-EBITDA
For the Medical Care Facilities subindustry, Surgery Partners's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgery Partners's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Surgery Partners's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Surgery Partners's EV-to-EBITDA falls into.
Surgery Partners's current Enterprise Value is €5,735 Mil.
Surgery Partners's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €440 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgery Partners (FRA:1SP) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Surgery Partners's PE Ratio for today is calculated as:
Surgery Partners's share price for today is €23.20.
Surgery Partners's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Surgery Partners's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Surgery Partners Inc is one of the few remaining independent ambulatory surgery center operators in the U.S. with national scale. The firm operates surgical facilities in approximately 30 states in partnership with physician groups and larger local healthcare systems. While surgical procedures drive a majority of the firm's revenue, the company also operates a clinical lab, urgent care facilities, and a handful of physician practices to provide additional healthcare services within the communities it serves. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:1SP has been successfully added to your 